StockData
Glucose Health, Inc. logo

Glucose Health, Inc. (GLUC) stock

GLUCOTCMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
Financials through Q3 FY2017, quarter ended Sep 30, 2017Last filing: 10-Q on Nov 14, 2017
$0.44+0.10 (+28.76%)

Close on Oct 19, 2026Market cap $1.82MP/E –Yield –

Glucose Health operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

Glucose Health's operating income for the twelve months ending Sep 30, 2017 was -$32.45K. For fiscal 2016 it was -$86.65K. The highest annual figure on record is -$86.65K in fiscal 2016.

Annual operating income

PeriodPeriod endValueChange
FY2016Dec 31, 2016-$86.65K–
FY2015Dec 31, 2015-$156.17K–
FY2014Dec 31, 2014-$545.22K–
FY2013Dec 31, 2013-$1.27M–
FY2012Dec 31, 2012-$361.42K–
FY2011Dec 31, 2011-$888.81K–
FY2010Dec 31, 2010-$614.85K–

Quarterly operating income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2017Sep 30, 2017$4.64K–
Q2 FY2017Jun 30, 2017$16.08K+166.5%
Q1 FY2017Mar 31, 2017-$28.31K–
Q4 FY2016Dec 31, 2016-$24.85K–
Q3 FY2016Sep 30, 2016-$55.56K–
Q2 FY2016Jun 30, 2016$6.03K–
Q1 FY2016Mar 31, 2016-$12.28K–
Q4 FY2015Dec 31, 2015-$14.91K–
Q3 FY2015Sep 30, 2015-$34.17K–
Q2 FY2015Jun 30, 2015-$42.38K–
Q1 FY2015Mar 31, 2015-$64.72K–
Q4 FY2014Dec 31, 2014-$361.03K–
Q3 FY2014Sep 30, 2014-$64.07K–
Q2 FY2014Jun 30, 2014-$80.19K–
Q1 FY2014Mar 31, 2014-$39.93K–
Q4 FY2013Dec 31, 2013-$558.15K–
Q3 FY2013Sep 30, 2013-$233.06K–
Q2 FY2013Jun 30, 2013-$285.57K–
Q1 FY2013Mar 31, 2013-$192.51K–
Q4 FY2012Dec 31, 2012-$124.20K–
Q3 FY2012Sep 30, 2012-$208.97K–
Q2 FY2012Jun 30, 2012-$21.27K–
Q1 FY2012Mar 31, 2012-$6.98K–
Q4 FY2011Dec 31, 2011-$171.06K–
Q3 FY2011Sep 30, 2011-$160.42K–
Q2 FY2011Jun 30, 2011-$452.96K–
Q1 FY2011Mar 31, 2011-$104.39K–
Q4 FY2010Dec 31, 2010-$143.48K–
Q3 FY2010Sep 30, 2010-$49.44K–

More Glucose Health figures

See a number that looks wrong?